000			01956 a2200541 4500
005			20250516053019.0
264		0	_c20120201
008			201202s 0 0 eng d
022			_a1744-7682
024	7		_a10.1517/14712598.2011.615741 _2doi
040			_aNLM _beng _cNLM
100	1		_aGulley, James L
245	0	0	_aA pilot safety trial investigating a vector-based vaccine targeting carcinoembryonic antigen in combination with radiotherapy in patients with gastrointestinal malignancies metastatic to the liver. _h[electronic resource]
260			_bExpert opinion on biological therapy _cNov 2011
300			_a1409-18 p. _bdigital
500			_aPublication Type: Clinical Trial; Journal Article; Research Support, N.I.H., Intramural
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aCancer Vaccines _xadverse effects
650	0	4	_aCarcinoembryonic Antigen _xgenetics
650	0	4	_aColonic Neoplasms _xgenetics
650	0	4	_aFowlpox virus _xgenetics
650	0	4	_aGenetic Vectors
650	0	4	_aHumans
650	0	4	_aLiver Neoplasms _xgenetics
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aNational Cancer Institute (U.S.)
650	0	4	_aPilot Projects
650	0	4	_aRadiation Dosage
650	0	4	_aRadiotherapy, Adjuvant
650	0	4	_aRadiotherapy, Conformal _xadverse effects
650	0	4	_aRectal Neoplasms _xgenetics
650	0	4	_aTime Factors
650	0	4	_aTreatment Outcome
650	0	4	_aUnited States
650	0	4	_aVaccines, Synthetic _xtherapeutic use
700	1		_aMadan, Ravi A
700	1		_aTsang, Kwong-Yok
700	1		_aArlen, Philip M
700	1		_aCamphausen, Kevin
700	1		_aMohebtash, Mahsa
700	1		_aKamrava, Mitchell
700	1		_aSchlom, Jeffrey
700	1		_aCitrin, Deborah
773	0		_tExpert opinion on biological therapy _gvol. 11 _gno. 11 _gp. 1409-18
856	4	0	_uhttps://doi.org/10.1517/14712598.2011.615741 _zAvailable from publisher's website
999			_c21113542 _d21113542